Trial intelligence / Profile preview

Intermittent Naltrexone Among Polysubstance Users

NCT01723384Phase 2Completed

Sponsor
University of California, San Francisco
Start
May 2013
Primary completion
Oct 2014
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of naltrexone in methamphetamine use disorder (MUD), alcohol use disorder (AUD), sponsored by University of California, San Francisco. Started May 2013; status: completed.

02

Drugs

naltrexone
03

Conditions

methamphetamine use disorder (MUD)alcohol use disorder (AUD)

Beyond the preview

Go deeper on NCT01723384.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01723384.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call